NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 34 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,000 | -50.0% | 141,508 | +18.1% | 0.00% | – |
| Q1 2022 | $50,000 | -81.6% | 119,847 | -73.6% | 0.00% | – |
| Q4 2021 | $272,000 | +130.5% | 454,320 | +358.1% | 0.00% | – |
| Q3 2021 | $118,000 | -5.6% | 99,183 | +7.9% | 0.00% | – |
| Q2 2021 | $125,000 | +681.2% | 91,939 | +832.2% | 0.00% | – |
| Q1 2021 | $16,000 | -98.3% | 9,863 | -97.5% | 0.00% | – |
| Q4 2020 | $956,000 | – | 395,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 45,849 | $8,000 | 0.60% |
| Aisling Capital Management LP | 90,000 | $16,000 | 0.01% |
| Frazier Life Sciences Management, L.P. | 425,650 | $77,000 | 0.01% |
| Values First Advisors, Inc. | 43,728 | $8,000 | 0.01% |
| Virtu Financial LLC | 127,585 | $23,000 | 0.00% |
| CCG WEALTH MANAGEMENT, LLC | 10,000 | $2,000 | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 125 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 42,738 | $7,000 | 0.00% |